findmyKOL

William Wierda, MD, PhD

Enriched profile

Professor of Medicine (Leukemia); Deputy Department Chair, Department of Leukemia; Executive Medical Director, Inpatient Medical Services; Section Chief, Chronic Lymphocytic Leukemia; Center Medical Director, Leukemia Center; Jane and John Justin Distinguished Chair in Leukemia Research in Honor of Dr. Elihu Estey (2022–Present) · The University of Texas MD Anderson Cancer Center

ORCID↗NPI↗
✓ Full profile
RegionHouston, TX · South CentralSpecialtyHematology / OncologyFocusChronic Lymphocytic Leukemia Research+4
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2009–2014

William Wierda is Professor of Medicine (Leukemia); Deputy Department Chair, Department of Leukemia; Executive Medical Director, Inpatient Medical Services; Section Chief, Chronic Lymphocytic Leukemia; Center Medical Director, Leukemia Center; Jane and John Justin Distinguished Chair in Leukemia Research in Honor of Dr. Elihu Estey (2022–Present) at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 1,533 publications with 63,208 citations (h-index 122); ClinicalTrials.gov lists 19 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

William G. Wierda is Professor of Medicine (Leukemia) at The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Leukemia, Division of Cancer Medicine. The public record shows 1,533 publications with 63,208 citations (h-index 122), centered on Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 18 registered clinical trials, 2 NIH-funded awards (2009–2014).

  • Most recent indexed publication: 2026 · Blood
  • Top research focus: Chronic Lymphocytic Leukemia Research
  • 18 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Leukemia (AML/ALL/CML/CLL)18 trialsLeukemia, Lymphocytic, Chronic, B-Cell10 trialsLeukemia, Lymphoid10 trialsLymphoma3 trialsLeukemia, Myeloid, Acute1 trial

Research focus

OpenAlex concept fingerprint
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsImmunodeficiency and Autoimmune Disorders

Drugs & molecules

across trials, industry payments and publications
Venclextageneric · VenetoclaxClinical trials2Industry payments15Publications12Calquencegeneric · AcalabrutinibClinical trials1Industry payments10Publications6Gazyvageneric · ObinutuzumabClinical trials1Industry payments1Publications8IbrutinibClinical trials—Industry payments5Publications13FludarabineClinical trials9Industry payments—Publications5RituximabClinical trials9Industry payments—Publications4CyclophosphamideClinical trials7Industry payments—Publications4Jaypircageneric · PirtobrutinibClinical trials—Industry payments3Publications4EltrombopagClinical trials1Industry payments—Publications1OfatumumabClinical trials1Industry payments—Publications1Epkinlygeneric · EpcoritamabClinical trials—Industry payments5Publications—AlemtuzumabClinical trials2Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials—Industry payments36Abbvie Inc.Clinical trials—Industry payments18M.D. Anderson Cancer CenterClinical trials15Industry payments—AstraZeneca Pharmaceuticals LPClinical trials—Industry payments14Hikma Pharmaceuticals USAClinical trials—Industry payments5Genentech, Inc.Clinical trials—Industry payments4AstraZeneca UK LimitedClinical trials—Industry payments2BeiGene USA, Inc.Clinical trials—Industry payments2Lilly USA, LLCClinical trials—Industry payments2Memgen, LLCClinical trials2Industry payments—Sobi, IncClinical trials—Industry payments2Adaptive Biotechnologies CorporationClinical trials—Industry payments1Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments1Celgene CorporationClinical trials—Industry payments1Chronic Lymphocytic Leukemia Research ConsortiumClinical trials1Industry payments—Genentech USA, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,533publications

Distinct works indexed by OpenAlex, matched via ORCID; 44 in PubMed.

63,208citations

Total citations across indexed works.

122h-index

Hirsch index (OpenAlex). i10-index 587.

Clinical & industry

trials, payments and federal funding
19clinical trials

Investigator role on registered studies.

View trials ↓
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2009–2014

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:

All 19 trial records: search, sort and filter.Explore →

Industry payments

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 27 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    48.3%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor23.3%
    Valacyclovir100%
    Part D≥21 patients
    Fluoroquinolone Antibacterial14.2%
    Levofloxacin100%
    Part D≥13 patients

    + 1 more class in this area

  • Cancer & immunology

    41.7%
    BCL-2 Inhibitor25.8%
    Venclexta100%
    Part D<11 patients
    Kinase inhibitor15.8%
    Calquence100%
    Part D<11 patients

  • Musculoskeletal

    10%
    Xanthine oxidase inhibitor10%
    Allopurinol100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

2 NIH research awards on record, funded 2009–2014 per NIH RePORTER. The latest:

All 10 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 44 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
    2,383 citations2017
    doi.org ↗
  2. 02
    Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
    2,249 citations2013
    doi.org ↗
  3. 03
    Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
    2,145 citations2020
    doi.org ↗
  4. 04
    Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
    1,887 citations2015
    doi.org ↗
  5. 05
    Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
    892 citations2015
    doi.org ↗
All 1,533 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Michael J. Keating577Hagop M. Kantarjian548Alessandra Ferrajoli478Jan A. Burger376Nitin Jain330Susan O’Brien329Guillermo Garcia‐Manero318Jörge E. Cortes316Farhad Ravandi311Zeev Estrov297Elias Jabbour265Tapan M. Kadia239Gautam Borthakur230Stefan Faderl199Susan O’Brien194Philip A. Thompson189Varsha Gandhi183Naveen Pemmaraju168Marina Konopleva165Thomas J. Kipps159Srđan Verstovšek148Courtney D. DiNardo131Constantine S. Tam128Susan Lerner115Naval Daver113Paolo Ghia112Deborah A. Thomas111Nicholas J. Short104Koji Sasaki103Ian W. Flinn97Koichi Takahashi93Preetesh Jain91Prithviraj Bose86Jennifer R. Brown86Sherry Pierce84William Plunkett84John C. Byrd82Steven M. Kornblau82Tanya Siddiqi80Matthew S. Davids79

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/william-wierda-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/william-wierda-77014510

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • LinkedIn

    linkedin.com/in/william-wierda-b1915616

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/William-Wierda

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/scientific-contributions/William-G-Wierda-2069413081

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/wwierda

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    cllglobal.org/cll-global-research-foundation-president-dr-william-wierda

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cllglobal.org ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Texas Medical Board license
    2001
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →faculty.mdanderson.org ↗
  • Subspecialty Fellowship

    Hematology and Oncology, University of California, San Diego

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Internship and Residency

    Internal Medicine, Duke University Medical Center

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • M.D.

    University of Health Sciences/The Chicago Medical School, North Chicago, IL

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Ph.D.

    Microbiology and Immunology, University of Health Sciences/The Chicago Medical School

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • B.S.

    Biochemistry, University of California, Riverside

    1986
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗

Editorial & leadership roles

journal and society appointments
  • Associate Editor

    Clinical Lymphoma, Myeloma & Leukemia

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Editorial Board

    Journal of Clinical Oncology

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Voting Member

    International Workshop on Chronic Lymphocytic Leukemia (iwCLL)

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Chair

    NCCN CLL/SLL and Hairy Cell Leukemia Guidelines Panel

    2017
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Editorial Board Member

    Leukemia Journal

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Member

    American College of Physicians, American Society of Hematology, American Society of Clinical Oncology, American Association of Immunologists, European Society of Hematology, Society of Hematologic Oncology (SOHO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • President and CEO

    CLL Global Research Foundation

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Faculty

    Chronic Lymphocytic Leukemia Research Consortium (CRC), UC San Diego

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cll.ucsd.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.